Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $21,314 | $19,573 | $19,307 | $16,662 |
| % Growth | 8.9% | 1.4% | 15.9% | – |
| Cost of Goods Sold | $9,957 | $8,835 | $8,348 | $7,289 |
| Gross Profit | $11,357 | $10,738 | $10,959 | $9,373 |
| % Margin | 53.3% | 54.9% | 56.8% | 56.3% |
| R&D Expenses | $3,476 | $2,802 | $2,917 | $2,713 |
| G&A Expenses | $5,119 | $5,193 | $5,039 | $5,231 |
| SG&A Expenses | $15,195 | $13,777 | $14,168 | $13,451 |
| Sales & Mktg Exp. | $10,076 | $8,584 | $9,129 | $8,220 |
| Other Operating Expenses | $392 | $450 | $452 | $456 |
| Operating Expenses | $19,063 | $17,029 | $17,537 | $16,620 |
| Operating Income | -$7,706 | -$6,291 | -$6,578 | -$7,247 |
| % Margin | -36.2% | -32.1% | -34.1% | -43.5% |
| Other Income/Exp. Net | -$1,671 | -$4,983 | -$3,799 | -$980 |
| Pre-Tax Income | -$9,377 | -$11,274 | -$10,377 | -$8,227 |
| Tax Expense | $176 | $172 | $49 | $187 |
| Net Income | -$9,553 | -$11,446 | -$10,426 | -$8,414 |
| % Margin | -44.8% | -58.5% | -54% | -50.5% |
| EPS | -0.32 | -0.28 | -0.26 | -0.21 |
| % Growth | -14.3% | -7.7% | -23.8% | – |
| EPS Diluted | -0.32 | -0.28 | -0.26 | -0.21 |
| Weighted Avg Shares Out | 30,243 | 40,848 | 40,360 | 39,652 |
| Weighted Avg Shares Out Dil | 30,243 | 40,848 | 40,360 | 39,652 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,088 | $1,155 | $1,206 | $1,222 |
| Depreciation & Amortization | $136 | -$3,059 | -$1,856 | $983 |
| EBITDA | -$4,553 | -$9,350 | -$8,434 | -$6,264 |
| % Margin | -21.4% | -47.8% | -43.7% | -37.6% |